Norwest Venture Partners Biotech Portfolio

3 Biotech companies backed by Norwest Venture Partners, including SetPoint Medical, Avalyn Pharma.

Norwest Venture Partners — Biotech accounts for 5 tracked companies with verified cap-table data, 5 of which disclose round sizes totalling $918M. The median disclosed raise is $200M, and the largest is Apreo Health at $212M, ahead of Avalyn Pharma ($211M) and Galvanize Therapeutics ($200M).

The names that recur most often on these portfolio cap tables are Norwest Venture Partners (5 companies), F-Prime Capital (2 companies), T. Rowe Price (2 companies), Bain Capital Life Sciences (1 company), Intuitive Ventures (1 company), Lightstone Ventures (1 company). By latest disclosed round, the market skews Series B (2), Series D (2), Series C (1).

Best funded Norwest Venture Partners — Biotech companies

  1. Apreo Health — $212M (latest: Series B)
  2. Avalyn Pharma — $211M (latest: Series B)
  3. Galvanize Therapeutics — $200M (latest: Series C)
  4. CytoVale — $180M (latest: Series D)
  5. Nectero Medical — $116M (latest: Series D)

Norwest Venture Partners — related firms and companies (56)

Norwest Venture Partners profile · All research reports